14Nov 2019

SIGNIFICANCE OF RAISED SERUM URIC ACID LEVELS IN PATIENTS WITH CHRONIC KIDNEY DISEASE

  • Assistant Professor, Dept of Biochemistry , Kurnool Medical College, Kurnool
  • Professor and HOD, Dept of Biochemistry , Kurnool Medical College, Kurnool
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: Hyperuricemia is common in chronic kidney disease (CKD). The present study evaluated the associations between baseline serum uric acid levels with mortality and end-stage renal disease (ESRD). Chronic kidney disease (CKD) is a serious condition associated with premature mortality, decreased quality of life, and increased health - care expenditures. Chronic kidney disease occurs when one suffers from gradual and usually permanent loss of kidney function over time. Material and Method: This is a prospective observational study conducted in Nephrology Dept affliated to Biochemistry Dept, Govt.General Hospital,Kurnool From June 2018 to may 2019. In this study, 158 CKD patients were studied with detailed clinical and laboratory examination and divided into two groups: one group included 60 CKD patients with raised serum uric acid and another group containing 98 CKD patients with normal serum uric acid. Both groups were age matched. Results: In our study, prevalence of raised serum uric acid in CKD patients was found to be 38.4%. It is observed that, CKD patients with raised serum uric acid were predominantly male and presented mainly in later part of life. There is statistically significant (p<0.05) positive correlation is found between serum uric acid and stages and severity of CKD, hypertension, diabetes mellitus, serum BUN, serum creatinine, urine albuminuria, anaemia, cardiovascular disease, mortality and negative correlation with eGFR . Conclusion: In CKD patients, higher serum uric acid levels were associated with higher degree of renal dysfunction, hypertension, diabetes, urine albuminuria, anaemia, cardiovascular disease and mortality. It is found that most common cause of mortality in CKD patients with raised serum uric acid was cardiovascular disease/events.

  1. Dharan KS, John GT, Neelakantan N, Korula A, Balakrishnan N, Kirubakaran MG, Jacob CK. Spectrum of severe chronic kidney disease in India: a clinicopathological study Natl Med J India. 2006 Sep-Oct; 19(5):250-2.
  2. Filiopoulos V, Hadjiyannakos D, and Vlassopoulos D. New insights into uric acid effects on the progression and prognosis of chronic kidney disease. Ren Fail. 2012, 34(4): p. 510- 20. 12.
  3. Eknoyan G. Rememberance of things past. Port J NephrolHypert. 2011; 25(4): 239-245.
  4. Levey AS, Andreoli SP, Dubose T, Provenzano P, Collins AJ. Chronic KidneyDisease: common, harmful and treatable. World kidney day, 2007. J Am SocNephrol. 2007; 18(2):374378?.
  5. National Kidney Foundation. K/DOQI Clinical Practice Guidlines for
  6. Chronic Kidney Disease: evaluation, classification and stratification. Am J
  7. Kidney Dis. 2002; 39(2) (suppl 1):S18266?.
  8. Eknoyan G. Chronic kidney disease: the quest for refinements. idney Int.2007; 72(10): 1183-1185.
  9. Gilbertson DT, Liu J, Xue JL et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am SocNephrol 2005; 16: 3736-3741.
  10. Robert C. Atkins, Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia, The epidemiology of chronic kidney disease, Kidney International, Vol. 67, Supplement 94 (2005), pp. S14-S18.
  11. King H, Aubert RE, Herman WH. Global burden of diabetes 1995 -2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;14141431.
  12. Kher V. End-stage renal disease in developing countries. Kidney Int. 2002;350-362.
  13. SK, Dash SC, Irshad M et al. Prevalence of chronic renal failure in adults in Delhi, India. Nephrol Dial Transplant. 2005; 20: 1638-1642.
  14. Joshi R, Magnolia C, Srinivas I, et al. Chronic diseases now leading cause of death in rural India-mortality data from the Andhra Pradesh rural health initiative. Int J Epidemiol, 2006;35 (6):1522-9.
  15. Rosenfeld, L. Four Centuries of Clinical Chemistry. New York: Taylor and Francis; 1999.
  16. Behrend Robert (1925). ?ZurGeschi chte der Hamsauresynthesen? Justus
  17. LiebigsAnnalen der Chemie(in German) (Weinheim, BadenWurtte? m berg, Germany: WILEY-UCH VerlagGmbH and Co. KGaA) 441(1): 215-216.
  18. McCrudden, F. Uric acid: the chemistry, physiology andpathology of uric acid and the physiologically important purine bodies, with a discussion of the metabolism in gout. Paul Hoeber Medical Books; 1905.
  19. Haig A. Uric acid as a factor in causation of disease. London: J and A Churchill; 1897.
  20. Alexander So and Bernard Thorens, Uric acid transport and disease, J Clin Invest. 2010;120(6):1791-1799.
  21. Dennis J. Levinson And Leif B. Sorensen, Renal handling of uric acid in normal and gouty subjects: evidence for a 4-component system, Annals of the Rheumatic Diseases, 1980, 39, 173-179.
  22. Choi HK, Mount DB, Reginato AM, American College of Physicians & American Physiological Society Pathogenesis of gout. Ann. Intern. Med. 2005;143:499-516.
  23. Joanne Bargman, Karl Skorecki. Harrison?s principle of Internal medicine, 18th Edition, Chapter 280 Chronic Kidney Didease, p 2308.
  24. Y. Sautin and R. J. Johnson, ?Uric acid: the oxidantantioxidant paradox,? Nucleosides, Nucleotides and Nucleic Acids, vol. 27, no. 6-7, pp. 608-619, 2008.
  25. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183-1190.
  26. Diana I. Jalal, Michel Chonchol, Wei Chen, and Giovanni Targher, Uric Acid as a Target of Therapy in CKD, Am J Kidney Dis. 2013 January; 61(1): 134-146.
  27. Daniel I. Feig, Uric acid - a novel mediator and marker of risk in chronic kidney disease?,CurrOpinNephrolHypertens. Author manuscript; available in PMC 2010 November 1.
  28. -H. Kang, T. Nakagawa, L. Feng et al., ?A role for uric acid in the progression of renal disease,? Journal of the American Society of Nephrology, vol. 13, no. 12, pp. 2888-2897,2002.
  29. -H. Kang, S.-K. Park, I.-K. Lee, and R. J. Johnson, ?Uric acid-induced C-reactive protein expression: implication on cell proliferation andnitric oxide production of human vascular cells,? Journal of the American Society of Nephrology, vol. 16, no. 12, pp. 3553-3562,2005.
  30. JayantaPaul, SomnathDasgupta, Association of Hyperuricemia With Carotid Intima-Media Thickness, Albuminuria,Diabetes, Hypertension in Chronic Renal Failure, World J Nephrol Urol. 2012;1(2-3):66-72.
  31. Busuioc, L. Voroneanu, S. Hogas, M. Covic, P. GusbethTatomir? and A. Covic, Pathogenetic Impact of Hyperuricemia in Renal and Cardiovascular Disease, BANTAO Journal 2007: 5 (1): 1.
  32. Punam Yadav, Dinkar Malik, SandeepKuma, Vijai Malik, A Role Of Serum Uric Acid In Chronic Renal Failure Patients And Its Effects, International
  33. Journal Of Scientific Research And Education, Volume 2 Issue 3 Pages 434-442 2014 ISSN (e): 2321-7545.
  34. Magdalena Madero, Mark J Sarnak, Xuelei Wang, Tom Greene, Gerald J Beck, John W Kusek, Allan J Collins, Andrew S Levey, and VandanaMenon, Uric Acid and Long-term Outcomes in CKD, Am J Kidney Dis. 2009 May; 53(5): 796-803.

[Venkateswarlu and Padma Vijaya Sree (2019); SIGNIFICANCE OF RAISED SERUM URIC ACID LEVELS IN PATIENTS WITH CHRONIC KIDNEY DISEASE Int. J. of Adv. Res. 7 (Nov). 881-888] (ISSN 2320-5407). www.journalijar.com

Dr.A.Padmavijayasree
Kurnool medical collt

DOI:

Article DOI: 10.21474/IJAR01/10090      
DOI URL: https://dx.doi.org/10.21474/IJAR01/10090

Download Full Paper

Download PDF No. of Downloads: 14 | No. of Views: 51